A novel synthetic approach to 2‐aryltetralones with high ee has been developed through asymmetric 1,4‐addition of arylboronic acids to naphthoquinone monoketals catalyzed by a rhodium complex with the ( R,R )‐Ph‐bod* ligand. The asymmetric addition proceeded in high yields with excellent enantioselectivity.
No takes yet. Share an insight, caveat, or question.
Tokunaga et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: